MRKR Q3'26 Earnings: revenue estimate is 2.12M USD
Okuma süresi: 1 dakikadan kısa
MRKR (Marker Therapeutics, Inc.) is set to announce its Q3'26 results on November 05, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).
For Q3'26, revenue estimate is 2.12 million USD with EPS (earnings per share) anticipated at (0.12) USD. Learn more details at MRKR Financials page.
Revenue & EPS values are provided in USD
| Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | |
|---|---|---|---|---|---|
| Revenue Reported | 1.23 M | 1.10 M | 800.00 K | 700.00 K | — |
| Revenue Estimate | 723.00 K | 682.10 K | 783.90 K | 660.67 K | 2.12 M |
| Revenue Surprise | +70.53% | +61.27% | +2.05% | +5.95% | |
| EPS Reported | (0.12) | (0.10) | (0.16) | (0.09) | |
| EPS Estimate | (0.36) | (0.19) | (0.16) | (0.13) | (0.12) |
| EPS Surprise | +66.67% | +47.58% | +0.00% | +29.13% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.